High dose therapy and autologous stem cell transplant does not improve survival compared with continued combination chemotherapy in people at high risk of relapse after initial treatment of advanced Hodgkin's lymphoma.
University Health Network, Princess Margaret Hospital, Toronto, Ont., Canada. donna.reece@uhn.on.ca
Donna E
DE
Reece
Anna
A
Sureda